The goal of the Gold Spring Harbor Laboratory Cancer Center is to promote interdisciplinary and high quality basic research on different aspects of cancer. The Cancer Center is organized into four established research programs. The Oncogene Program focuses on the genetics of human cancer and the faction of oncogene products in signal transduction. The Gene Expression Program focuses on the regulation of gene expression in normal and cancer cells and the controls that govern cell growth and division. The Tumor Virus Program concentrates on the mechanisms of virus induced cell transformation and HIV infection in AIDS. This program focuses on fundamental cellular processes such as transcription, DNA replication, messenger RNA splicing and translation as they relate to cancer. The Structure and Computation program studies the function of proteins by X- ray crystallography and conducts research on computer assisted methods for genetic analysis. The Center has a number of Shared Resources that facilitate the research within the Programs, including Animal, Microscopy, Shared Instrumentation, Fluorescent In Situ Hybridization, Flow Cytometry, Monoclonal Antibody, Nucleic Acid Chemistry, Protein Chemistry, Tissue Procurement, Graphic Arts and 2D-Gel facilities, as well as Central Services, Computer Services and Developmental Funds. These Programs and facilities are organized into a coordinated Center with a clearly defined Administrative structure that promotes scientific excellence in cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA045508-13
Application #
2894727
Study Section
Cancer Centers and Research Programs Review Committee (CCRP)
Program Officer
Marino, Michael A
Project Start
1987-08-01
Project End
2000-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
13
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
Tiriac, Hervé; Belleau, Pascal; Engle, Dannielle D et al. (2018) Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov 8:1112-1129
Forcier, Talitha L; Ayaz, Andalus; Gill, Manraj S et al. (2018) Measuring cis-regulatory energetics in living cells using allelic manifolds. Elife 7:
Naguib, Adam; Mathew, Grinu; Reczek, Colleen R et al. (2018) Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells. Cell Rep 23:58-67
Aberle, M R; Burkhart, R A; Tiriac, H et al. (2018) Patient-derived organoid models help define personalized management of gastrointestinal cancer. Br J Surg 105:e48-e60
Bhagwat, Anand S; Lu, Bin; Vakoc, Christopher R (2018) Enhancer dysfunction in leukemia. Blood 131:1795-1804
Khan, Jalal A; Maki, Robert G; Ravi, Vinod (2018) Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment. J Clin Oncol 36:194-201
Chen, Wei-Chia; Tareen, Ammar; Kinney, Justin B (2018) Density Estimation on Small Data Sets. Phys Rev Lett 121:160605
Cheng, Derek; Tuveson, David (2018) Kras in Organoids. Cold Spring Harb Perspect Med 8:
Albrengues, Jean; Shields, Mario A; Ng, David et al. (2018) Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361:
Cook, Natalie; Basu, Bristi; Smith, Donna-Michelle et al. (2018) A phase I trial of the ?-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Br J Cancer 118:793-801

Showing the most recent 10 out of 380 publications